Telo Genomics Corp Stock Buy Hold or Sell Recommendation

TDSGF Stock  USD 0.07  0.01  13.58%   
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding Telo Genomics Corp is 'Strong Sell'. Macroaxis provides Telo Genomics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TDSGF positions.
  
Check out Telo Genomics Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool.
Note, we conduct extensive research on individual companies such as Telo and provide practical buy, sell, or hold advice based on investors' constraints. Telo Genomics Corp. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in price.

Execute Telo Genomics Buy or Sell Advice

The Telo recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Telo Genomics Corp. Macroaxis does not own or have any residual interests in Telo Genomics Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Telo Genomics' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell Telo GenomicsBuy Telo Genomics
Strong Sell

Market Performance

Very WeakDetails

Volatility

Out of controlDetails

Hype Condition

StaleDetails

Current Valuation

Fairly ValuedDetails

Odds Of Distress

Quite HighDetails

Economic Sensitivity

Moves indifferently to market movesDetails

Analyst Consensus

Not AvailableDetails

Reporting Quality (M-Score)

UnavailableDetails
For the selected time horizon Telo Genomics Corp has a Mean Deviation of 7.75, Standard Deviation of 14.04 and Variance of 197.06
We provide advice to complement the current expert consensus on Telo Genomics. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure Telo Genomics Corp is not overpriced, please validate all Telo Genomics fundamentals, including its cash and equivalents and the relationship between the current ratio and net asset . As Telo Genomics Corp appears to be a penny stock we also recommend to double-check its shares owned by institutions numbers.

Telo Genomics Trading Alerts and Improvement Suggestions

Telo Genomics Corp generated a negative expected return over the last 90 days
Telo Genomics Corp has high historical volatility and very poor performance
Telo Genomics Corp has some characteristics of a very speculative penny stock
Telo Genomics Corp has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (2.11 M) with profit before overhead, payroll, taxes, and interest of 0.
Telo Genomics Corp has accumulated about 2.69 M in cash with (1.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.05.

Telo Genomics Returns Distribution Density

The distribution of Telo Genomics' historical returns is an attempt to chart the uncertainty of Telo Genomics' future price movements. The chart of the probability distribution of Telo Genomics daily returns describes the distribution of returns around its average expected value. We use Telo Genomics Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Telo Genomics returns is essential to provide solid investment advice for Telo Genomics.
Mean Return
-0.34
Value At Risk
-19.77
Potential Upside
30.00
Standard Deviation
14.04
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Telo Genomics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Telo Genomics Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Telo Genomics or Health Care Technology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Telo Genomics' price will be affected by overall otc stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Telo otc's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α
Alpha over Dow Jones
-0.35
β
Beta against Dow Jones-0.02
σ
Overall volatility
14.15
Ir
Information ratio -0.03

Telo Genomics Volatility Alert

Telo Genomics Corp is displaying above-average volatility over the selected time horizon. Telo Genomics Corp is a penny stock. Although Telo Genomics may be in fact a good investment, many penny otc stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Telo Genomics Corp. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Telo instrument if you perfectly time your entry and exit. However, remember that penny otcs that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.

Telo Genomics Fundamentals Vs Peers

Comparing Telo Genomics' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Telo Genomics' direct or indirect competition across all of the common fundamentals between Telo Genomics and the related equities. This way, we can detect undervalued stocks with similar characteristics as Telo Genomics or determine the otc stocks which would be an excellent addition to an existing portfolio. Peer analysis of Telo Genomics' fundamental indicators could also be used in its relative valuation, which is a method of valuing Telo Genomics by comparing valuation metrics with those of similar companies.
    
 Better Than Average     
    
 Worse Than Average Compare Telo Genomics to competition
FundamentalsTelo GenomicsPeer Average
Return On Equity-0.78-0.31
Return On Asset-0.45-0.14
Current Valuation13.73 M16.62 B
Shares Outstanding59.42 M571.82 M
Shares Owned By Insiders6.52 %10.09 %
Shares Owned By Institutions1.83 %39.21 %
Price To Earning(0.67) X28.72 X
Price To Book10.46 X9.51 X
EBITDA(2.05 M)3.9 B
Net Income(2.11 M)570.98 M
Cash And Equivalents2.69 M2.7 B
Cash Per Share0.05 X5.01 X
Total Debt40 K5.32 B
Debt To Equity0.01 %48.70 %
Current Ratio14.66 X2.16 X
Book Value Per Share0.04 X1.93 K
Cash Flow From Operations(1.79 M)971.22 M
Earnings Per Share(0.03) X3.12 X
Number Of Employees1618.84 K
Beta1.87-0.15
Market Capitalization12.81 M19.03 B
Total Asset2.83 M29.47 B
Net Asset2.83 M

Telo Genomics Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Telo . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About Telo Genomics Buy or Sell Advice

When is the right time to buy or sell Telo Genomics Corp? Buying financial instruments such as Telo OTC Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having Telo Genomics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Currency Funds Thematic Idea Now

Currency Funds
Currency Funds Theme
Funds or Etfs investing in a single currency or combination of currencies from different countries in order to replicate respective foreign exchange markets. The Currency Funds theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Currency Funds Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Telo OTC Stock

Telo Genomics financial ratios help investors to determine whether Telo OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Telo with respect to the benefits of owning Telo Genomics security.